Misu, Hirofumi http://orcid.org/0000-0003-3286-8464
Funding for this research was provided by:
Japan Society for the Promotion of Science (23791022, 25461334, 16K09740)
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Article History
Received: 29 July 2018
Accepted: 9 August 2018
First Online: 17 August 2018
Compliance with ethical standards
:
: Hirofumi Misu received research grant from Eli Lilly, Takeda Pharmaceutical Company, Novartis International AG, and Merck & Co., Inc.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study. All experimental protocols were approved by the Ethics Committees of Kanazawa University (Approval no. 2009-067, December 1 2009, Approval no. 2011-049, October 12 2011, and Approval no. 2014-002, September 30 2014).
: All institutional and national guidelines for the care and use of laboratory animals were followed.